Agriculture & Agritech Global On demand · 24-48h

Global Gold-198 Seeds Source Market Strategic Research Report

Global Gold-198 Seeds Source Market Strategic Research Repor…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Gold-198 Seeds Source Market
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Sterile, Non-sterile

By Application: Hospital, Cancer Center

Key Players: Best Medical International, Chengdu Gaotong Isotope Co., Ltd., Beijing Zhibo Hi-Tech Biotechnology Co., Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2024 · forecast to 2032
Length: 85 pages

Overzicht

Scope of the Report

In 2024, global Gold-198 Seeds Source production reached approximately 8.08 k units, with an average global market price of around US$ 52 per unit.

Gold-198 seeds are used in permanent seed implant therapy involving injecting approximately 30-100 radioactive seeds into the prostate gland. They give off their radiation at a low dose rate over several weeks, and then the seeds can remain in the prostate gland permanently. Brachytherapy can be used for a wide range of prostate stages, PSA values, and tumor grades. The components and dosages are modified for those with low, intermediate, or high risk prostate cancer. This treatment can also be used for many tumors which are considered too advanced for radical prostatectomy. As long as there is no obvious spread to distant areas of the body, like the bones, this treatment may be considered. For early stages, treatment may be an alternative to the radical prostatectomy, but with less side effects.

Gold-198 seed sources are primarily used in brachytherapy, particularly in cancer treatment.

High doses are delivered directly to the tumor, minimizing damage to surrounding healthy tissue. Their short half-life allows for rapid decay of radioactivity after treatment, reducing long-term radiation risks. They are implanted via catheter or puncture, minimizing surgical trauma.

Gold-198 sealed seed sources remain an effective treatment for localized tumors such as liver and prostate cancer. Future advancements in radiotherapy technology are expected to lead to even more precise applications. Despite facing competition from newer radionuclides, their short half-life and high dose advantages are expected to maintain stable market demand.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Gold-198 Seeds Source market?

What factors are driving Gold-198 Seeds Source market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Gold-198 Seeds Source market opportunities vary by end market size?

How does Gold-198 Seeds Source break out by Type, by Application?

This report presents a comprehensive overview of the global Gold-198 Seeds Source market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Sterile
  • Non-sterile

Segment by Application

  • Hospital
  • Cancer Center

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Gold-198 Seeds Source market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Cancer Center evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Segments covered in this report

By Type
SterileNon-sterile
By Application
HospitalCancer Center

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Sterile
  • 3.1.3 Non-sterile
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Cancer Center
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Best Medical International
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Chengdu Gaotong Isotope Co., Ltd.
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Beijing Zhibo Hi-Tech Biotechnology Co., Ltd.
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is Gold-198 Seeds Source?
In 2024, global Gold-198 Seeds Source production reached approximately 8.08 k units, with an average global market price of around US$ 52 per unit.
How is the Gold-198 Seeds Source market segmented by type?
By type, the market is segmented into Sterile and Non-sterile.
What are the key applications of Gold-198 Seeds Source?
Key applications covered include Hospital and Cancer Center.
Which companies are profiled in the Gold-198 Seeds Source market report?
Key players profiled include Best Medical International, Chengdu Gaotong Isotope Co. and Beijing Zhibo Hi-Tech Biotechnology Co..
What geographies does the Gold-198 Seeds Source market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Gold-198 Seeds Source?
What factors are driving Gold-198 Seeds Source market growth, globally and by region?
Who should buy the Gold-198 Seeds Source market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital and Cancer Center, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Gold-198 Seeds Source market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.